Abstract:Journal of Digestive DiseasesVolume 9, Issue 2 p. 108-112 Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases* Min De ZENG, Min De ZENG Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai,Search for more papers by this authorJian Gao FAN, Jian Gao FAN Department of Gastroenterology, Shanghai First People's Hospital, Jiaotong University, Shanghai,Search for more papers by this authorLun Gen LU, Lun Gen LU Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai,Search for more papers by this authorYou Ming LI, You Ming LI Department of Gastroenterology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou,Search for more papers by this authorCheng Wei CHEN, Cheng Wei CHEN Clinical Center for Hepatology, No. 85 Army Hospital, Shanghai,Search for more papers by this authorBing Yuan WANG, Bing Yuan WANG Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang, ChinaSearch for more papers by this authorYi Min MAO, Yi Min MAO Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai,Search for more papers by this author Min De ZENG, Min De ZENG Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai,Search for more papers by this authorJian Gao FAN, Jian Gao FAN Department of Gastroenterology, Shanghai First People's Hospital, Jiaotong University, Shanghai,Search for more papers by this authorLun Gen LU, Lun Gen LU Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai,Search for more papers by this authorYou Ming LI, You Ming LI Department of Gastroenterology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou,Search for more papers by this authorCheng Wei CHEN, Cheng Wei CHEN Clinical Center for Hepatology, No. 85 Army Hospital, Shanghai,Search for more papers by this authorBing Yuan WANG, Bing Yuan WANG Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang, ChinaSearch for more papers by this authorYi Min MAO, Yi Min MAO Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai,Search for more papers by this author First published: 16 April 2008 https://doi.org/10.1111/j.1751-2980.2008.00331.xCitations: 123 : Min De ZENG, Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200001, China. Email: xhsyljd@yahoo.com.cn * The Chinese National Consensus Workshop on nonalcoholic fatty liver diseases was organized by Chinese Society of Hepatology, Chinese Medical Association. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume9, Issue2May 2008Pages 108-112 RelatedInformation

Interpretation of Clinical Trial Guidelines for Nonalcoholic Steatohepatitis

Clinical trials of investigational new drugs for nonalcoholic steatohepatitis:challenges in design and practice

Clinical guidelines of non-alcoholic fatty liver disease: A systematic review.

The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review

Guidelines of prevention and treatment for alcoholic liver disease (2018, China).

Attitudes of Chinese Patients with Non-alcoholic Fatty Liver Disease Toward Participation in Clinical Trials from a National Multicenter Survey

General Characteristics and Clinical Practices of Chinese Patients with Non-Alcoholic Fatty Liver Disease

The similarities and differences between American and Chinese guidelines for alcoholic liver disease.

Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design

Development of new drugs for the treatment of non‐alcoholic steatohepatitis

Understanding and Explanation on Chinese and Overseas Guidelines of the Diagnosis and Treatment in the Nonalcoholic Fatty Liver Disease.

Guideline of prevention and treatment of nonalcoholic fatty liver disease (2018, China).

An interpretation of European guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease

Guidelines for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Diseases

Guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease in children and adults in China and for-eign countries:comparison and analysis

Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis

Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis

Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial

Epidemiological Characteristics and Management of Nonalcoholic Fatty Liver Disease/nonalcoholic Steatohepatitis in China: A Narrative Review

A clinical interpretation of 2012 American guideline on the diagnosis and management of nonalcoholic fatty liver disease

Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway